Mirae Asset Global ETFs Holdings
ARCT icon

Mirae Asset Global ETFs Holdings’s Arcturus Therapeutics ARCT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Sell
12,341
-21,961
-64% -$173K ﹤0.01% 2911
2026
Q1 		$265K Buy
34,302
+1,130
+3% +$8.24K ﹤0.01% 2202
2025
Q4 		$203K Buy
33,172
+3,235
+11% +$34.9K ﹤0.01% 2344
2025
Q3 		$552K Sell
29,937
-2,395
-7% -$38.5K ﹤0.01% 1822
2025
Q2 		$421K Buy
32,332
+16,306
+102% +$193K ﹤0.01% 1903
2025
Q1 		$172K Buy
16,026
+483
+3% +$7.67K ﹤0.01% 2394
2024
Q4 		$263K Buy
15,543
+341
+2% +$6.42K ﹤0.01% 2246
2024
Q3 		$350K Buy
15,202
+876
+6% +$18.7K ﹤0.01% 2092
2024
Q2 		$349K Buy
+14,326
New +$434K ﹤0.01% 1982

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ARCT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Arcturus Therapeutics (ARCT) stake by 64% in Q2 2026, selling an estimated $173K and leaving 12,341 shares worth $82.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

Mirae Asset Global ETFs Holdings first reported a position in ARCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $552K in Q3 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 12,341 shares of Arcturus Therapeutics worth $82.9K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 21,961 Arcturus Therapeutics shares in Q2 2026, an estimated $173K.
  • Arcturus Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2911 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Arcturus Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Arcturus Therapeutics position peaked at $552K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.